Clinical trial Recruiting at 2 sites Observational Ages 18 and up

Using digital voice analysis to assess frailty and distress in patients

Official title: Digital Voice Analysis as a Measure of Frailty and Distress. A Feasibility Study (DIVAN)

Run by University Hospital, Basel, Switzerland · NCT05783401 · Data updated 2026-11-12

This study is testing if analyzing patients' voices can help doctors understand changes in frailty and emotional distress in people with active cancer.

More Frailty trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment100 (estimated)
SponsorUniversity Hospital, Basel, Switzerland
Academic / other
Locations2 sites (Basel and 1 other locations)
StatusRecruiting
StartedNovember 19, 2022
Main results expectedNovember 2025
Study endsNovember 2025
Registry record updatedJanuary 17, 2025
Trial IDNCT05783401 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults aged 18 and older with active cancer or hematological malignancies who can communicate in German.

Probably not a fit

Patients with severe voice alterations, cognitive impairments, or those with a life expectancy of less than 14 days may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to evaluate whether digital voice analysis (DVA) can quantitatively measure changes in frailty and emotional distress in patients, particularly those with active cancer. By recording audio samples from patients using various devices, the study will analyze specific acoustic parameters over time to identify correlations with the patients' wellbeing. The approach includes having patients describe images to facilitate relaxed speech, allowing for both inter-subject and intra-subject comparisons of audio features and clinical evaluations. This innovative methodology seeks to provide a more objective means of monitoring frailty and distress in individuals who may struggle to communicate their needs.

Why it matters

Potential benefit: If successful, this study could lead to improved early detection and monitoring of frailty and distress in patients, enabling more tailored and effective care.

How similar studies have gone: While the use of digital voice analysis is a relatively novel approach, existing studies have shown promise in using voice features for health assessments, suggesting potential for success in this area.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Active cancer or haemato-oncological malignancy
* Adults (≥ 18 years)
* Ability to understand, speak and read German language fluently
* Ability to provide written consent
* Sufficient or corrected vision to see the images
* Sufficient auditory comprehension for participation in the study based on the therapist's clinical opinion
* Ability to concentrate for 20-30 minutes based on the investigator's clinical opinion
* Signed informed consent to the study

Exclusion Criteria:

* Aphonia, dysphonia or other obvious voice alterations of patient's voice
* Life-expectancy shorter ≤ 14 days as judged by a physician or nurse via "surprise question"
* Breathlessness whilst speaking
* Cognitive impairment as judged by physician or Mini-Cog in the G8 screening tool
* Severe physical, emotional or existential suffering because of which the enrollment and participation in the study would result in patient burden, as judged by the treating physicians and their multiprofessional team members

Where it's running

  • Palliativzentrum Hildegard, Basel
    Basel, Switzerland
    Recruiting
  • Kantonsspital Baselland, Klinik für Onkologie, Hämatologie und Immuntherapie
    Liestal, Switzerland
    Recruiting

Study contacts

  • Principal investigator: Marcus Vetter, PD Dr. med. — Kantonsspital Baselland, Klinik für Onkologie, Hämatologie und Immuntherapie
  • Study coordinator: Marcus Vetter, PD Dr. med.
  • Email: marcus.vetter@ksbl.ch
  • Phone: +41 61 925 2525

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.